SCHEMBL14007258

SCHEMBL14007258

CCOCCn1cc(C(=O)NCCC(c2ccccc2)c2ccccc2)ccc1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 11/20 1.00
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TPSAB1 Q15661 1/20 0.45
CASR P41180 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
BRD4 O60885 1/20 0.42
BRD2 P25440 1/20 0.42
BRD3 Q15059 1/20 0.42
BRDT Q58F21 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14007266 0.91 EPHX2 (0.83) EPHX2MEN1KMT2ACYP2C9CYP2C19
SCHEMBL14007235 0.90 EPHX2 (0.82) EPHX2MEN1KMT2ATPSAB1CYP2C9
SCHEMBL14007242 0.86 EPHX2 (0.76) EPHX2MEN1KMT2ATPSAB1CYP2C9
SCHEMBL14007236 0.84 EPHX2 (0.72) EPHX2MEN1KMT2ATPSAB1CYP2C9
SCHEMBL14007247 0.82 EPHX2 (0.70) EPHX2MEN1KMT2ATPSAB1CYP2C9
SCHEMBL13702264 0.81 EPHX2 (0.68) EPHX2KMT2ABRD4BRD2BRD3
SCHEMBL14034441 0.81 EPHX2 (0.67) EPHX2MEN1KMT2ATPSAB1CYP2C9
SCHEMBL14007254 0.80 EPHX2 (0.67) EPHX2MEN1KMT2ATPSAB1CASR
SCHEMBL14007268 0.80 EPHX2 (0.66) EPHX2CYP2C9CYP2C19NPC1RAB9A
SCHEMBL14007245 0.80 EPHX2 (0.66) EPHX2MEN1KMT2ATPSAB1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed
WO-2007044491-A1 N-SUBSTITUTED PYRIDINONE OR PYRIMIDINONE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors EPHX1, EPHX2, DOHH EPHX2 2/4885MEN1 3669/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.